Literature DB >> 32758646

Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination.

Jinghui Zhang1, Haoxun Wang1, Yunzhou Fan1, Zhou Yu1, Guofeng You2.   

Abstract

The members of the organic anion transporter (OAT) family are mainly expressed in kidney, liver, placenta, intestine, and brain. These transporters play important roles in the disposition of clinical drugs, pesticides, signaling molecules, heavy metal conjugates, components of phytomedicines, and toxins, and therefore critical for maintaining systemic homeostasis. Alterations in the expression and function of OATs contribute to the intra- and inter-individual variability of the therapeutic efficacy and the toxicity of many drugs, and to many pathophysiological conditions. Consequently, the activity of these transporters must be highly regulated to carry out their normal functions. This review will present an update on the recent advance in understanding the cellular and molecular mechanisms underlying the regulation of renal OATs, emphasizing on the post-translational modification (PTM), the crosstalk among these PTMs, and the remote sensing and signaling network of OATs. Such knowledge will provide significant insights into the roles of these transporters in health and disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug disposition; Drug transporter; Organic anion transporter; Post-translational modification; Regulation

Mesh:

Substances:

Year:  2020        PMID: 32758646      PMCID: PMC7770002          DOI: 10.1016/j.pharmthera.2020.107647

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  196 in total

Review 1.  The fast-growing business of SUMO chains.

Authors:  Helle D Ulrich
Journal:  Mol Cell       Date:  2008-11-07       Impact factor: 17.970

2.  Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo.

Authors:  Masatsune Ogura; Makoto Ayaori; Yoshio Terao; Tetsuya Hisada; Maki Iizuka; Shunichi Takiguchi; Harumi Uto-Kondo; Emi Yakushiji; Kazuhiro Nakaya; Makoto Sasaki; Tomohiro Komatsu; Hideki Ozasa; Fumitaka Ohsuzu; Katsunori Ikewaki
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-08-04       Impact factor: 8.311

3.  Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury.

Authors:  Hideyuki Saito; Misato Yoshimura; Chika Saigo; Megumi Komori; Yui Nomura; Yuko Yamamoto; Masataka Sagata; Ayaka Wakida; Erina Chuman; Kazuhiko Nishi; Hirofumi Jono
Journal:  Toxicol Sci       Date:  2014-06-23       Impact factor: 4.849

4.  SENP2 regulates hepatocellular carcinoma cell growth by modulating the stability of β-catenin.

Authors:  Huo-Jian Shen; Hong-Yi Zhu; Chao Yang; Fu Ji
Journal:  Asian Pac J Cancer Prev       Date:  2012

5.  Transcriptional regulation of human organic anion transporter 1 by B-cell CLL/lymphoma 6.

Authors:  Waja Wegner; Gerhard Burckhardt; Maja Henjakovic
Journal:  Am J Physiol Renal Physiol       Date:  2014-09-18

6.  The deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel.

Authors:  Michael B Butterworth; Robert S Edinger; Huib Ovaa; Danny Burg; John P Johnson; Raymond A Frizzell
Journal:  J Biol Chem       Date:  2007-10-29       Impact factor: 5.157

7.  The type I TGF-beta receptor is covalently modified and regulated by sumoylation.

Authors:  Jong Seok Kang; Elise F Saunier; Rosemary J Akhurst; Rik Derynck
Journal:  Nat Cell Biol       Date:  2008-05-11       Impact factor: 28.824

8.  Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.

Authors:  Anisha K Nigam; Julia G Li; Kaustubh Lall; Da Shi; Kevin T Bush; Vibha Bhatnagar; Ruben Abagyan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2020-01-02       Impact factor: 5.157

Review 9.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.

Authors:  Bing Gong; Miroslav Radulovic; Maria E Figueiredo-Pereira; Christopher Cardozo
Journal:  Front Mol Neurosci       Date:  2016-01-26       Impact factor: 5.639

Review 10.  Sumoylation regulates diverse biological processes.

Authors:  J Zhao
Journal:  Cell Mol Life Sci       Date:  2007-12       Impact factor: 9.261

View more
  10 in total

1.  Emerging Roles of the Human Solute Carrier 22 Family.

Authors:  Sook Wah Yee; Kathleen M Giacomini
Journal:  Drug Metab Dispos       Date:  2021-12-17       Impact factor: 3.579

2.  Peptide Hormone Insulin Regulates Function, Expression, and SUMOylation of Organic Anion Transporter 3.

Authors:  Jinghui Zhang; Guofeng You
Journal:  AAPS J       Date:  2021-03-11       Impact factor: 3.603

3.  Changes in the intestinal expression of drug metabolism-related genes in a piglet model of parenteral nutrition.

Authors:  Li-Na Dai; Yu-Ling Zhao; Lu Jiang; Jun-Kai Yan
Journal:  Nutr Metab (Lond)       Date:  2022-03-09       Impact factor: 4.169

4.  Protein kinase C regulates organic anion transporter 1 through phosphorylating ubiquitin ligase Nedd4-2.

Authors:  Zhou Yu; Chenchang Liu; Jinghui Zhang; Zhengxuan Liang; Guofeng You
Journal:  BMC Mol Cell Biol       Date:  2021-10-18

5.  Molecular Properties of Drugs Handled by Kidney OATs and Liver OATPs Revealed by Chemoinformatics and Machine Learning: Implications for Kidney and Liver Disease.

Authors:  Anisha K Nigam; Anupam A Ojha; Julia G Li; Da Shi; Vibha Bhatnagar; Kabir B Nigam; Ruben Abagyan; Sanjay K Nigam
Journal:  Pharmaceutics       Date:  2021-10-18       Impact factor: 6.321

6.  Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury.

Authors:  Min Liu; Qiong Huang; Yan Zhu; Li Chen; Yumei Li; Zhicheng Gong; Kelong Ai
Journal:  Mater Today Bio       Date:  2022-02-08

7.  In Vitro Characterization of Renal Drug Transporter Activity in Kidney Cancer.

Authors:  Pedro Caetano-Pinto; Nathanil Justian; Maria Dib; Jana Fischer; Maryna Somova; Martin Burchardt; Ingmar Wolff
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

8.  Organic Anion Transporters (OAT) and Other SLC22 Transporters in Progression of Renal Cell Carcinoma.

Authors:  Thomas C Whisenant; Sanjay K Nigam
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

9.  Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp.

Authors:  Ran Fu; Xiao-Nan Wang; Cai-Hui Guo; Ying Li; Cong-Yang Ding; Ya-Jing Li; Zhan-Jun Dong
Journal:  Ann Transl Med       Date:  2021-05

Review 10.  What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis.

Authors:  Raymond Vanholder; Sanjay K Nigam; Stéphane Burtey; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2022-03-17       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.